2 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Speech Disorders: new trials by email Literature Review of Speech Disorders trials Research Report on Speech Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BIIB092 in Primary Tauopathies: CBS, nfvPPA, sMAPT, and TES BIIB092, Placebo - Primary Tauopathies, Corticobasal Degeneration Syndrome | Phase 1 | Terminated | University of California, San Francisco | 22 | 2018-09-12 | 2019-12-19 |
| Evaluating Anodal tDCS Preceding Aphasia Therapy transcranial direct current stimulation - Stroke, Aphasia | Phase 1 / Phase 2 | Terminated | Northwell Health | 15 | 2014-09-01 | 2021-04-05 |
Aphasia (1) · Apraxias (1) · Color Vision Defects (1) · Communication Disorders (1) · Pick Disease of the Brain (1) · Primary Progressive Nonfluent Aphasia (1) · Stroke (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Language Disorders (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Aphasia (1) · Aphasia, Primary Progressive (1) · Cardiovascular Diseases (1) · Cerebrovascular Disorders (1) · Communication Disorders (1)
Transcranial Direct Current Stimulation (1) · gosuranemab (1)
Northwell Health (1) · University of California, San Francisco (1)
United States (2)